ClinicalMetric / Countries / South Korea / stroke
← 🇰🇷 South Korea Trials
🇰🇷 South Korea Country × Condition

stroke Clinical Trials in South Korea

Active clinical trials for stroke with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 3 // Recruiting: 3 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇰🇷 South Korea

Active Trials in South Korea (3)

NCT07558876
Recruiting

Task-Oriented Upper Limb Training With Focal Vibration in Stroke

Enrollment
38 pts
Country
🇰🇷 South Korea
Jisu Kim
View Trial →
NCT06270238
Recruiting

Efficacy of Personalized Repetitive Transcranial Magnetic Stimulation Protocol Based on Functional Reserve to Enhance Upper Limb Function in Subacute Stroke Patients

Enrollment
120 pts
Country
🇰🇷 South Korea
Samsung Medical Center
View Trial →
NCT06380049
Recruiting

Predicting Fall Risk in Stroke Patients Using a Machine Learning Model and Multi-Sensor Data

Enrollment
90 pts
Country
🇰🇷 South Korea
Seoul National University Hospital
View Trial →

Frequently Asked Questions

How many stroke clinical trials are active in South Korea?
There are currently 3 active clinical trials for stroke with sites in South Korea, of which 3 are actively recruiting patients.
How can I join a stroke clinical trial in South Korea?
To join a stroke clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are stroke trials in South Korea?
Active stroke trials in South Korea span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All South Korea Trials → Global stroke Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology